Latest news with #Jabour
Associated Press
27-04-2025
- Business
- Associated Press
Rony Jabour, a Leading Voice in Workplace Safety, to Speak at NSC Congress & Expo 2025 in Denver
Rony Jabour set to inspire the future of workplace safety at the NSC Congress & Expo 2025 in Denver. BOSTON, MA, UNITED STATES, April 27, 2025 / / -- In September 2025, the stage of the National Safety Council (NSC) Congress & Expo — the largest and most prestigious workplace safety event in the United States — will feature Rony Jabour, one of the most respected figures in occupational safety education today. With a journey that spans continents — from a small town in Brazil to America's leading safety forums — Jabour has been transforming how safety is taught and practiced across industries nationwide. His upcoming presentation, titled 'Building Bridges: Enhancing Workplace Safety for Workers in the U.S.', will focus on the critical need to foster safer environments for all workers, emphasizing inclusion, education, and leadership. The 2025 NSC Congress & Expo, to be held in Denver, Colorado, from September 12 to 18, is expected to attract tens of thousands of safety professionals, executives, and policymakers from across the globe. Registration opens on May 13. Drawing from over 15 years of hands-on experience training more than 50,000 workers, Jabour delivers a deeply human perspective shaped by personal tragedy — the loss of his father to a workplace accident. 'Safety isn't just a checklist or a policy — it's a mindset that must be embraced by everyone, from the boardroom to the job site,' Jabour states. He continues, 'Our goal is simple: every worker deserves to go home safe, every single day.' A graduate of Texas University with dual master's degrees in Risk Management and Safety & Health, and a distinguished alumnus of Harvard University's programs in Risk Analysis and Leadership & Management, Jabour brings a rare blend of academic rigor and practical expertise to the industry. Recognized as a '40 Under 40 Rising Star' by the National Safety Council and a 'Top 100 Leader in Education', Jabour's impact extends well beyond training sessions — he is shaping the future of workplace culture. Founder of United Safety Net, one of the largest occupational safety training organizations in the United States, Jabour is also the creator and organizer of Build Safe Connection, the largest event in the U.S. dedicated exclusively to construction and safety for immigrant workers — further reinforcing his commitment to building safer, more inclusive workplaces. For Jabour, safety transcends equipment and protocols. 'Safety is not about PPE; it's about going back home safely every day,' he emphasizes. With his message reaching new audiences at the NSC Congress & Expo 2025, Jabour is helping to redefine what it means to lead — and protect — in the modern workplace. USN USN +1 978-767-0630 email us here Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Associated Press
27-04-2025
- Business
- Associated Press
Rony Jabour to Speak on Workplace Safety at NSC Congress & Expo 2025 in Denver
DENVER, CO, UNITED STATES, April 27, 2025 / / -- Rony Jabour, an occupational safety educator and founder of United Safety Net, is scheduled to speak at the National Safety Council (NSC) Congress & Expo 2025 in Denver, Colorado. The event, considered the largest workplace safety conference in the United States, will take place from September 12 to 18, with registration opening on May 13. Jabour's presentation, 'Building Bridges: Enhancing Workplace Safety for Workers in the U.S.,' will address the need to strengthen safety practices across diverse workforces. His focus reflects more than 15 years of experience training workers and advocating for improved standards, especially in construction and high-risk industries. 'Safety isn't just a checklist or a policy — it's a mindset that must be embraced by everyone, from the boardroom to the job site,' Jabour said in an interview. He emphasized that 'safety is not about PPE; it's about going back home safely every day.' Born in Brazil and now based in the United States, Jabour holds dual master's degrees in Risk Management and Safety & Health from Texas University and additional certifications from Harvard University in Risk Analysis and Leadership & Management. He has been recognized as a '40 Under 40 Rising Star' by the National Safety Council and as one of the Top 100 Leaders in Education. In addition to his training work, Jabour is the founder and organizer of Build Safe Connection, an annual event that brings together construction professionals to promote safety practices, particularly among immigrant communities. The NSC Congress & Expo 2025 is expected to draw more than 15,000 safety professionals, policymakers, and industry leaders. Jabour's participation underscores his growing role in shaping discussions on workplace safety nationally. 'Our goal is simple,' Jabour said. 'Every worker deserves to go home safe, every single day.' USN USN +1 978-767-0630 email us here Legal Disclaimer: EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Associated Press
02-04-2025
- Health
- Associated Press
Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California
MICSC are leaders in Los Angeles providing MRI and Diagnostic Imaging services MICSC expands access to Nociscan beyond Beverly Hills now available in Santa Monica BROOMFIELD, Colo., April 02, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., ('Aclarion' or the 'Company') (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today its Nociscan product is now available in Santa Monica at Medical Imaging Center of Southern California (MICSC). Until now, MICSC has provided Nociscan exclusively at their Beverly Hills location. 'We are pleased to expand access to Nociscan in our Santa Monica location,' said Bradley Jabour, MD, founder of MICSC. 'MICSC has a proud heritage of adoption of new and novel solutions that add value to our patients and referring physician customers. Nociscan has been an integral part of our Beverly Hills service offering and by adding it in Santa Monica we are expanding our services while replicating the benefits to patients and physicians currently provided in Beverly Hills. Physicians treating low back pain are constantly striving for more and better information when diagnosing and treating patients. Nociscan is helping physicians who treat low back pain and we are pleased to offer Nociscan at both our Los Angeles locations.' In November 2024, Dr. Jabour was highlighted in an article about Nociscan in the Radiological Society of North America edition of MAGNETOM Flash, a peer-to-peer magazine published by Siemens Healthineers. The article features two physician-user perspectives on Nociscan, one from a spine surgeon and the other from Dr. Jabour's point of view as a radiologist and imaging center owner. Chronic low back pain (cLBP) is a global healthcare problem with approximately 266 million people worldwide suffering from degenerative spine disease and low back pain. Los Angeles is the most populous city in California, with an estimated population exceeding 3.8M people, and the second-most populous city in the United States, second only to New York City. Both Los Angeles and New York City are strategically important markets for Aclarion. Aclarion's Nociscan solution is the first evidence-supported SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Nociscan objectively quantifies chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain. To find a Nociscan center, view our site map here. All organizations cited and/or quotes from individuals not part of Aclarion have reviewed and approved the contents herein. About Aclarion, Inc. Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy ('MRS'), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies. For more information, please visit Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 about the Company's current expectations about future results, performance, prospects and opportunities. Statements that are not historical facts, such as 'anticipates,' 'believes' and 'expects' or similar expressions, are forward-looking statements. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company's current plans and expectations, as well as future results of operations and financial condition. These and other risks and uncertainties are discussed more fully in our filings with the Securities and Exchange Commission. Readers are encouraged to review the section titled 'Risk Factors' in the Company's Annual Report on Form 10-K for the year ended December 31, 2023, as well as other disclosures contained in the Prospectus and subsequent filings made with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Investor Contacts: Kirin M. Smith PCG Advisory, Inc. Media Contacts: Jennie Kim SPRIG Consulting
Yahoo
02-04-2025
- Health
- Yahoo
Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California
BROOMFIELD, Colo., April 02, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., ('Aclarion' or the 'Company') (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today its Nociscan product is now available in Santa Monica at Medical Imaging Center of Southern California (MICSC). Until now, MICSC has provided Nociscan exclusively at their Beverly Hills location. 'We are pleased to expand access to Nociscan in our Santa Monica location,' said Bradley Jabour, MD, founder of MICSC. 'MICSC has a proud heritage of adoption of new and novel solutions that add value to our patients and referring physician customers. Nociscan has been an integral part of our Beverly Hills service offering and by adding it in Santa Monica we are expanding our services while replicating the benefits to patients and physicians currently provided in Beverly Hills. Physicians treating low back pain are constantly striving for more and better information when diagnosing and treating patients. Nociscan is helping physicians who treat low back pain and we are pleased to offer Nociscan at both our Los Angeles locations.' In November 2024, Dr. Jabour was highlighted in an article about Nociscan in the Radiological Society of North America edition of MAGNETOM Flash, a peer-to-peer magazine published by Siemens Healthineers. The article features two physician-user perspectives on Nociscan, one from a spine surgeon and the other from Dr. Jabour's point of view as a radiologist and imaging center owner. Chronic low back pain (cLBP) is a global healthcare problem with approximately 266 million people worldwide suffering from degenerative spine disease and low back pain. Los Angeles is the most populous city in California, with an estimated population exceeding 3.8M people, and the second-most populous city in the United States, second only to New York City. Both Los Angeles and New York City are strategically important markets for Aclarion. Aclarion's Nociscan solution is the first evidence-supported SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Nociscan objectively quantifies chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain. To find a Nociscan center, view our site map here. For more information on Nociscan, please email: info@ All organizations cited and/or quotes from individuals not part of Aclarion have reviewed and approved the contents herein. About Aclarion, Inc. Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy ('MRS'), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies. For more information, please visit Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 about the Company's current expectations about future results, performance, prospects and opportunities. Statements that are not historical facts, such as 'anticipates,' 'believes' and 'expects' or similar expressions, are forward-looking statements. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company's current plans and expectations, as well as future results of operations and financial condition. These and other risks and uncertainties are discussed more fully in our filings with the Securities and Exchange Commission. Readers are encouraged to review the section titled 'Risk Factors' in the Company's Annual Report on Form 10-K for the year ended December 31, 2023, as well as other disclosures contained in the Prospectus and subsequent filings made with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Investor Contacts: Kirin M. SmithPCG Advisory, Media Contacts: Jennie KimSPRIG Consultingjennie@
